Source link : https://www.newshealth.biz/health-news/fda-expands-darzalex-faspro-indication-in-myeloma/
The US Food and Drug Administration (FDA) has approved daratumumab and hyaluronidase-fihj (Darzalex Faspro, Janssen Research and Development, LLC) in combination with bortezomib, lenalidomide, and dexamethasone for induction and consolidation in transplant-eligible patients with newly diagnosed multiple myeloma. Approval followed priority review and was based on efficacy and safety findings from the open-label PERSEUS trial […]
Author : News Health
Publish date : 2024-08-01 07:32:10
Copyright for syndicated content belongs to the linked Source.
Categories